Nava-Ocampo Alejandro A, Alarcón-Almanza Juan M, Moyao-García Diana, Ramírez-Mora Juan Carlos, Salmerón Jorge
Department of Anesthesia and Respiratory Therapy, Hospital Infantil de México Federico Gómez, México DF, México.
Fundam Clin Pharmacol. 2004 Feb;18(1):107-12. doi: 10.1046/j.0767-3981.2003.00214.x.
The present study was performed in order to identify the cost of drugs used without documenting them in the patients' file and the wastage of drugs in a pediatric anesthesiology ward. In a prospective, blinded, observational design, drug utilization of 610 consecutive patients, undergoing an elective or emergency surgical procedure was evaluated. The number of undocumented drugs per 100 requested units and the number of wasted drugs per 100 requested units were computed and multiplied by its corresponding unitary cost. The median undocumented cost was 92.4 US dollars (95% CI 17.2-216.6 dollars) per 100 requested units. Succinylcholine (40 mg/2 mL) was the main undocumented drug; its use was not documented in approximately 50% cases in which this neuromuscular blocking agent was requested. However, rocuronium and nalbuphine had the highest unjustified cost, 770.6 dollars and 847.0 dollars per 100 requested units, respectively. Ketorolac, diclofenac, metamizol, furosemide, methylprednisolone, sodium bicarbonate, and cisatracurium were requested and documented. The median cost of wasted drug was 141.8 dollars (95% CI 55.8-448.2 dollars) per 100 requested drugs. More than 80% of adrenaline, naloxone, flunitrazepam, ephedrine, and cisatracurium were wasted. However, the highest cost of wasted drugs was for ondansetron, cisatracurium, methylprednisolone, and rocuronium. The uncontrolled availability and use of drugs may represent an important amount of resources wasted without any awareness of the staff in a department of pediatric anesthesia.
本研究旨在确定在儿科麻醉病房中未记录在患者病历中的用药费用以及药物浪费情况。采用前瞻性、盲法、观察性设计,对610例接受择期或急诊手术的连续患者的药物使用情况进行评估。计算每100个申请单位中未记录药物的数量和浪费药物的数量,并乘以其相应的单价成本。每100个申请单位的未记录成本中位数为92.4美元(95%可信区间17.2 - 216.6美元)。琥珀酰胆碱(40mg/2mL)是主要的未记录药物;在约50%申请使用这种神经肌肉阻滞剂的病例中未记录其使用情况。然而,罗库溴铵和纳布啡的不合理成本最高,分别为每100个申请单位770.6美元和847.0美元。酮咯酸、双氯芬酸、安乃近、呋塞米、甲泼尼龙、碳酸氢钠和顺阿曲库铵有申请且有记录。每100个申请药物的浪费药物成本中位数为141.8美元(95%可信区间55.8 - 448.2美元)。超过80%的肾上腺素、纳洛酮、氟硝西泮、麻黄碱和顺阿曲库铵被浪费。然而,浪费药物成本最高的是昂丹司琼、顺阿曲库铵、甲泼尼龙和罗库溴铵。药物的无控制供应和使用可能意味着在儿科麻醉科工作人员未意识到的情况下浪费了大量资源。